Full circle: Startup scores big deal with Pfizer — and QB3 is happy Epsilon09242014-09-22T11:00:37-07:00September 22, 2014|In the News|
Circle Pharma Announces Receipt of Seed Funding and Initiation of Two Collaborations Epsilon09242023-07-19T07:12:33-07:00September 22, 2014|Press Releases|
Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? Epsilon09242013-08-28T12:00:38-07:00August 28, 2013|Publications on Macrocycles|
Form and function in cyclic peptide natural products: a pharmacokinetic perspective Epsilon09242013-05-21T12:30:09-07:00May 21, 2013|Publications|
Macrocycles and Constrained Peptides Epsilon09242013-04-11T12:00:46-07:00April 11, 2013|Publications on Macrocycles|
Predicting Efflux Ratios and Blood-Brain Barrier Penetration from Chemical Structure: Combining Passive Permeability with Active Efflux by P-Glycoprotein Epsilon09242012-12-02T12:00:19-08:00December 2, 2012|Publications|
Optimizing PK properties of cyclic peptides: the effect of side chain substitutions on permeability and clearance Epsilon09242012-10-03T12:40:59-07:00October 3, 2012|Publications|
Macrocycles in New Drug Discovery Epsilon09242012-08-02T12:00:30-07:00August 2, 2012|Publications on Macrocycles|
Testing physical models of passive membrane permeation Epsilon09242012-06-25T12:30:25-07:00June 25, 2012|Publications|
Predicting and improving the membrane permeability of peptidic small molecules Epsilon09242012-04-12T12:40:12-07:00April 12, 2012|Publications|